Tenax Therapeutics Inc.
Chart
Good to know: Investing in stocks tends to provide long-term positive returns, but it also involves risks. You can lose some or all of your investment. Past performance of this stock is not a reliable indicator of future results. Data from external providers has not been altered by Saxo. See full data disclaimer
About Tenax Therapeutics Inc.
Tenax Therapeutics Inc is a specialty pharmaceutical company focused on identifying, developing, and commercializing products that address cardiovascular and pulmonary diseases with high unmet medical needs. The company owns North American rights to develop and commercialize levosimendan and has released topline data regarding the Phase 2 clinical trial for the use of levosimendan in the treatment of Pulmonary Hypertension associated with Heart Failure and preserved Ejection Fraction.
/ 
Others were interested in
Frequently asked questions
To buy Tenax Therapeutics Inc. stock, open a Saxo account and fund it. With SaxoInvestor or SaxoTrader, you can easily search for Tenax Therapeutics Inc. by name or ticker, choose the number of shares, and place your order.
The ticker symbol for Tenax Therapeutics Inc. is TENX:xnas. You can use this code to quickly find the stock in Saxo’s platforms and track its price and performance.
Tenax Therapeutics Inc. has its primary listing on NASDAQ (Small cap). You can trade Tenax Therapeutics Inc. with a Saxo account, alongside thousands of other stocks worldwide.
Yes, Tenax Therapeutics Inc. is available to trade on SaxoInvestor and SaxoTraderGO. You can buy shares directly and include Tenax Therapeutics Inc. as part of a broader investment portfolio. Explore our SaxoInvestor platform.
Learn more about investing and trading at Saxo’s educational content hub. Explore portfolio strategies, types of stocks, diversification, and valuation measures— so you can make more informed decisions when considering shares like Tenax Therapeutics Inc..